Inflammation & Infection

Liquid ocular bandage launched in Europe

March 25, 2009

BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.

Novagali technologies allow greater drug access to the posterior of the eye

March 25, 2009

According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.

Retisert implant in sympathetic ophthalmia

March 18, 2009

The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.

Link between skin cancer and eye cancer

March 11, 2009

There is an association between uveal and a variety of skin melanomas, according to study results published in the March issue of Ophthalmology.

Uveitis study enters Phase IIa

March 04, 2009

ESBATech AG, a developer of antibody fragment therapeutics, has initiated a Phase IIa study in patients with acute anterior uveitis, designed to evaluate the safety, tolerability and clinical activity of topically applied ESBA105.

Causes of infectious scleritis

February 18, 2009

Fungus and microbial infection are the most common causes of infectious scleritis, according to study conclusions published in the February issue of Eye.

Anti-inflammatory enters Phase I/II

February 11, 2009

ESBA105, an anti-TNF alpha antibody fragment designed to reduce inflammation in patients undergoing cataract surgery, has begun a Phase Ib/IIa trial, according to an announcement from ESBATech AG, the antibody's developer.

Ocular herpes drug under FDA review

February 04, 2009

A New Drug Application (NDA) for ganciclovir ophthalmic gel 0.15% against herpetic keratitis, submitted by Sirion Therapeutics, Inc, has been accepted for review by the FDA.

Expanding our knowledge of dry AMD

February 01, 2009

Professor Scott Cousins explains how we can use our knowledge of drusen formation to find new ways to combat dry age-related macular degeneration.

Conjunctivitis drug reviewed by FDA

January 21, 2009

The FDA has accepted for review a New Drug Application for Bepreve (bepotastine ophthalmic solution; ISTA Pharmaceuticals) for the treatment of ocular itching associated with allergic conjunctivitis.